Regenerative Medicine

Regenerate & Recover.
Regenerative medicine stands as a beacon of hope and a testament to human ingenuity, marking the begining of a new era in healthcare and human evolution. This dynamic field combines the latest advancements in biopolymer sciences, tissue engineering, and cellular therapies to unlock the unparalleled potential of the human body to heal itself.

Technological Platforms

Advanced synthetic materials can transform the restoration, function and establishment of normal biological tissues.

These materials are engineered to mimic the complex biological structures of the human body, facilitating the growth and integration of new cells. Their versatility allows for the design of highly specialized scaffolds that can support cell attachment, proliferation, and differentiation, essential for tissue engineering.
It can be customized to degrade at a controlled rate, releasing bioactive molecules that promote healing and tissue regeneration, which minimizes the risk of rejection and other complications, offering new hope for patients with previously untreatable conditions.

Synthetic biology provides innovative solutions to complex biomedical challenges.

By redesigning biological systems or creating new ones, synthetic biology enables us to engineer cells, proteins, and genetic circuits that mimic natural processes. This capability is crucial for developing more effective therapies for tissue regeneration.
This intersection of biology and engineering not only accelerates the development of regenerative therapies but also opens new avenues for personalized medicine, making treatments more efficient and accessible.

Advanced proprietary equipment is a strategic asset for enhancing research capabilities

By designing and utilizing custom-made equipment, Roumai technology specifically designed to the unique demands of regenerative medicine.
This specialized approach allows for more precise control of environmental conditions, more efficient automation of complex biological processes, and enhanced scalability of tissue engineering and cell culture systems.

Product Pipeline

Proof of Concept

Preclinical Research

Clinical Phase I, II, III

Commercialization

RegeneVessel TEBV

MyColla

Electronic Blood Vessel

Proof of Concept

Regulatory Affairs

Commercialization

CellCoder Electroporator

RegeneColla